Saturday, 16 January 2021
|
|
| 10:00–10:15 am (15:00–15:15 GMT) (16:00–16:15 CET) |
Welcome and Introductions Cynthia Comella, MD (USA) (bio) |
| 10:15–10:45 am (15:15–15:45 GMT) (16:15–16:45 CET) |
Targeting Botulinum Toxin to Distal Sites and Diverse Nerve Terminals Matteo Caleo, PhD (Italy) (bio) |
| 10:45–11:15 am (15:45–16:15 GMT) (16:45–17:15 CET) |
Receptor Interactions of Botulinum Toxin: The “Sweet” Spots of BoNT/A and BoNT/E Rongsheng Jin, PhD (USA) (bio) |
| 11:15–11:45 am (16:15–16:45 GMT) (17:15–17:45 CET) |
Basis of Movement Control and Why Botulinum Toxin Should Influence It Alfredo Berardelli, MD (Italy) (bio) |
| 11:45 am–12:05 pm (16:45–17:05 GMT) (17:45–18:05 CET) |
Break |
| 12:05–1:50 pm (17:05–18:50 GMT) (18:05–19:50 CET) |
Guidance, Localization, Optimal Placement of Botulinum Toxin: What Works Best? Moderator – Cynthia Comella, MD (USA) (bio) Adult & Pediatric Spasticity – Katharine Alter, MD (USA) (bio) Cervical Dystonia – Richard Barbano, MD (USA) (bio) Limb Dystonia & Tremor – David Simpson, MD (USA) (bio) |
| 1:50–2:20 pm (18:50–19:20 GMT) (19:50–20:20 CET) |
Cosmetic Botulinum Toxin: Duration, Clinical Implications, and Uses Nowell Solish, MD (Canada) (bio) |
| 2:20–2:30 pm (19:20–19:30 GMT) (20:20–20:30 CET) |
Closing Remarks David Simpson, MD (USA) (bio) |
Sunday, 17 January 2021
|
|
| 10:00 am–2:00 pm (15:00–19:00 GMT) (16:00–20:00 CET) |
Industry Sponsored Sessions |
